The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1306
February 23, 2009
View Complete Issue         Table of Contents 2019 
PPI Interactions with Clopidogrel Revisted
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
PPI Interactions with Clopidogrel Revisted
February 23, 2009 (Issue: 1306)
Current guidelines recommend use of a proton pump inhibitor (PPI) to decrease the risk of gastrointestinal bleeding in patients taking clopidogrel (Plavix) with aspirin. A recent issue of The Medical Letter considered whether omeprazole (Prilosec,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: PPI Interactions with Clopidogrel Revisted
Article code: 1306a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.